Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy M Allen LaPointe

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Archives of Internal Medicine|June 26, 2003
Medication errors in hospitalized cardiovascular patientsNancy M Allen LaPointe, James G Jollis
American Heart Journal|March 10, 2010
In-hospital management of patients with atrial flutterNancy M Allen LaPointe, Jie-Lena Sun, Sigal Kaplan
Journal of Managed Care & Specialty Pharmacy|March 25, 2015
Challenges to integrating pharmacogenetic testing into medication therapy managementSusanne B Haga, Nancy M Allen LaPointe, Jivan Moaddeb
Pharmacotherapy|November 5, 2003
New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptanceNancy M Allen LaPointe, Carol A Pamer, Judith M Kramer
Journal of General Internal Medicine|March 14, 2007
Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptionsNancy M Allen LaPointe, Paul Pappas, Patricia Deverka, et al.
American Heart Journal|October 31, 2007
Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillationNancy M Allen LaPointe, Laura Governale, Jerry Watkins, et al.
Pharmacotherapy|August 14, 2002
Practitioner acceptance of the dofetilide risk-management programNancy M Allen LaPointe, Judith M Kramer, Kevin P Weinfurt, et al.
JAMA|April 24, 2003
What clinicians should know about the QT intervalSana M Al-Khatib, Nancy M Allen LaPointe, Judith M Kramer, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 10, 2003
Knowledge deficits related to the QT interval could affect patient safetyNancy M Allen LaPointe, Sana M Al-Khatib, Judith M Kramer, et al.
Pharmacogenomics|November 12, 2015
Incorporation of pharmacogenetic testing into medication therapy managementSusanne B Haga, Jivan Moaddeb, Rachel Mills, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Archives of Internal Medicine|June 26, 2003
Medication errors in hospitalized cardiovascular patientsNancy M Allen LaPointe, James G Jollis
American Heart Journal|March 10, 2010
In-hospital management of patients with atrial flutterNancy M Allen LaPointe, Jie-Lena Sun, Sigal Kaplan
Journal of Managed Care & Specialty Pharmacy|March 25, 2015
Challenges to integrating pharmacogenetic testing into medication therapy managementSusanne B Haga, Nancy M Allen LaPointe, Jivan Moaddeb
Pharmacotherapy|November 5, 2003
New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptanceNancy M Allen LaPointe, Carol A Pamer, Judith M Kramer
Journal of General Internal Medicine|March 14, 2007
Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptionsNancy M Allen LaPointe, Paul Pappas, Patricia Deverka, et al.
American Heart Journal|October 31, 2007
Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillationNancy M Allen LaPointe, Laura Governale, Jerry Watkins, et al.
Pharmacotherapy|August 14, 2002
Practitioner acceptance of the dofetilide risk-management programNancy M Allen LaPointe, Judith M Kramer, Kevin P Weinfurt, et al.
JAMA|April 24, 2003
What clinicians should know about the QT intervalSana M Al-Khatib, Nancy M Allen LaPointe, Judith M Kramer, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 10, 2003
Knowledge deficits related to the QT interval could affect patient safetyNancy M Allen LaPointe, Sana M Al-Khatib, Judith M Kramer, et al.
Pharmacogenomics|November 12, 2015
Incorporation of pharmacogenetic testing into medication therapy managementSusanne B Haga, Jivan Moaddeb, Rachel Mills, et al.
Pageof 7